Furthermore, in vivo interaction of Rgl2 and Ras was reported in a BioID-based proteomics study where Rgl2 was among other proximal interactors identified using HRas.G12V expressed in bladder cancer cells (Kovalski et al, 2019). The gene discussed is RGL2; the disease is urinary bladder carcinoma.